One exclusivity provision included in the FDA Modernization Act of 1997 targeted which drugs?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the BCPS Regulatory Test. Prepare with flashcards and multiple choice questions, each question includes hints and explanations to get you ready for the exam!

Multiple Choice

One exclusivity provision included in the FDA Modernization Act of 1997 targeted which drugs?

Explanation:
The key idea here is a pediatric exclusivity incentive. The FDA Modernization Act of 1997 added a provision that grants an extra six months of market protection to a drug if the sponsor completes FDA-requested pediatric safety and efficacy studies and submits the results. This incentive is designed to encourage studies in children across drugs, not to limit the benefit to a particular drug class. Therefore, the provision targeted pediatric drugs. It isn’t about cardiovascular drugs, nor is it about oral formulations, nor specifically about vaccines—the distinctive feature is the added protection tied to pediatric data.

The key idea here is a pediatric exclusivity incentive. The FDA Modernization Act of 1997 added a provision that grants an extra six months of market protection to a drug if the sponsor completes FDA-requested pediatric safety and efficacy studies and submits the results. This incentive is designed to encourage studies in children across drugs, not to limit the benefit to a particular drug class. Therefore, the provision targeted pediatric drugs. It isn’t about cardiovascular drugs, nor is it about oral formulations, nor specifically about vaccines—the distinctive feature is the added protection tied to pediatric data.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy